https://www.selleckchem.com/pr....oducts/Nanchangmycin
Introduction Current consensus recommends a protective effect of cytomegalovirus (CMV) infection on relapse after peripheral blood or bone marrow hematopoietic stem cell transplantation. However, in cord blood transplantation (CBT), studies of CMV infection, especially CMV viral load, on relapse are limited. Patients and Methods Wct e retrospectively analyzed the effect of CMV infection on 3-year outcomes in 249 AML patients according to CMV DNA load (DNA copies less then 1000/mL and DNA copies ≧1000/mL) within 100 days after CBT.
Me gusta
Comentario
Compartir
